Skip to content
healthcare.dev

fluticasone propionate and salmeterol

NDC 0054-0327, fluticasone propionate and salmeterol, powder, from Hikma Pharmaceuticals USA Inc..

Product NDC
0054-0327
Status
Listed
Labeler
Hikma Pharmaceuticals USA Inc.
Dosage form
POWDER
Route
RESPIRATORY (INHALATION)
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA203433
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0054-0327 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • SALMETEROL XINAFOATE50 ug/1
  • FLUTICASONE PROPIONATE250 ug/1

Pharmacologic classes

Adrenergic beta2-Agonists [MoA]; Corticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]; beta2-Adrenergic Agonist [EPC]

Package NDCNDC-11Package
0054-0327-56000540327561 POUCH in 1 CARTON (0054-0327-56) / 1 INHALER in 1 POUCH / 60 POWDER in 1 INHALER

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/f9fcfc90-3677-4a9b-900e-44417d50d507
  • NADAC price for package 00054032756

    GET /v1/drugs/nadac/00054032756

Use it

Look up 0054-0327 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0054-0327 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0054-0327. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.